← All investor calls
Cardumen Capital
Pre-seed: Digital biomarkers & neuro
€5M–€15M · Pre-seed · Apply by 13 Aug 2026 (GMT +1)
Investor calls are for startup accounts. Sign in or create a startup profile →
About this opportunity
Cardumen Capital is actively investing in this space. Deep-tech and health AI, pan-European. We back founders with clinical evidence and a clear go-to-market.
- Investment stage
- Pre-seed
- Typical ticket size
- €5M–€15M
Who should apply
- Therapeutic areas
- Neurology
- Service categories
- Digital biomarkerDiagnostics & detection
- Geographic focus
- Does not matter
- Regions
- APACEurope
- Startup stage
- Scaling - ExpansionPre-launch - Concept or Prototype
- Maximum age
- 2 years
- Business model
- Consumer/patients payCorporates pay (projects, white label, SAAS)Employers pay
Application questions
- What traction and clinical evidence do you have?
- What are you raising and on what terms?
- Why is now the right time for your company?
- If accepted
- Promising startups are invited to a first call with the investment team.